Sailila, Kisra H.
HRN: 22-81-17 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/29/2023
CEFTRIAXONE 1G (VIAL)
03/29/2023
04/04/2023
IV
2g
Q24H
Mild Traumatic Brain Injury; Lacerated Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueCentral Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes